 |
Dibenzothiazepines - Adverse effects
Research News and Information
Sunday, November 22, 2009
26 Oct 2009 
CONTEXT: Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication. OBJECTIVE: To study the association of ... Read more...
20 Aug 2009 BACKGROUND: The introduction of second-generation antipsychotic drugs during the 1990s is widely believed to have adversely affected mortality of patients with schizophrenia. Our aim was to establish the long-term contribution of antipsychotic drugs ... Read more...
Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
30 Jul 2009 OBJECTIVE: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. METHOD: Thirty-nine patients fulfilling DSM-IV-TR diagnostic criteria for schizophrenia and had depressive symptoms were studied ... Read more...
Latest indexed articles for 'Dibenzothiazepines - Adverse effects'
These are the very latest articles for this heading:
- Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. 26 Oct 2009
- FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
24 Aug 2009 - 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). 20 Aug 2009
- Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. 30 Jul 2009
- Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events. 30 Jul 2009
- Drug-induced Pisa syndrome under quetiapine. 27 Jul 2009
- Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population. 29 Jun 2009
- A commentary on "A young man with acute dilated cardiomyopathy associated with methylphenidate".
5 Jun 2009 - Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression. 30 May 2009
- Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose: the case for lipid rescue. 30 May 2009
- FDA panel issues mixed decision on quetiapine in depression and anxiety. 25 May 2009
- Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients. 24 May 2009
- Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. 19 May 2009
- FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia. 13 May 2009
- A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. 3 May 2009
- Akathisia and second-generation antipsychotic drugs. 29 Apr 2009
- Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need. 29 Apr 2009
- Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia. 29 Apr 2009
- Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report. 29 Apr 2009
- Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. 26 Apr 2009
See a longer list of these articles.
Technical information about 'Dibenzothiazepines'
Registry Number: 0
Descriptor UI: D003987
Alternative terms: Dibenzothiazepines;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D02.886.680.702.500; D03.494.276;
History Note: 68